These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6086215

  • 1. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [Abstract] [Full Text] [Related]

  • 2. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E, Limbert M, Seeger K, Seibert G, Novick WJ.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC.
    Rev Infect Dis; 1982 Jun; 4 Suppl():S374-8. PubMed ID: 6294786
    [Abstract] [Full Text] [Related]

  • 4. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN, Barry AL, Packer RR.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [Abstract] [Full Text] [Related]

  • 5. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE, Sanders CV, Marier RL.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [Abstract] [Full Text] [Related]

  • 6. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R, Nightingale CH, Tilton R.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [Abstract] [Full Text] [Related]

  • 7. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
    Kobayashi S, Arai S, Hayashi S, Sakaguchi T, Kawana R.
    Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
    Winstanley TG, Spencer RC.
    Drugs Exp Clin Res; 1986 May; 12(12):967-71. PubMed ID: 3471432
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN, Wilson HW.
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA, Henry D, Ngui-Yen J, Castell A, Coderre S.
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.